219 related articles for article (PubMed ID: 35144588)
1. Association between plasma sRAGE and emphysema according to the genotypes of AGER gene.
Sin S; Lim MN; Kim J; Bak SH; Kim WJ
BMC Pulm Med; 2022 Feb; 22(1):58. PubMed ID: 35144588
[TBL] [Abstract][Full Text] [Related]
2. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.
Cheng DT; Kim DK; Cockayne DA; Belousov A; Bitter H; Cho MH; Duvoix A; Edwards LD; Lomas DA; Miller BE; Reynaert N; Tal-Singer R; Wouters EF; Agustí A; Fabbri LM; Rames A; Visvanathan S; Rennard SI; Jones P; Parmar H; MacNee W; Wolff G; Silverman EK; Mayer RJ; Pillai SG;
Am J Respir Crit Care Med; 2013 Oct; 188(8):948-57. PubMed ID: 23947473
[TBL] [Abstract][Full Text] [Related]
3. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
Pratte KA; Curtis JL; Kechris K; Couper D; Cho MH; Silverman EK; DeMeo DL; Sciurba FC; Zhang Y; Ortega VE; O'Neal WK; Gillenwater LA; Lynch DA; Hoffman EA; Newell JD; Comellas AP; Castaldi PJ; Miller BE; Pouwels SD; Hacken NHTT; Bischoff R; Klont F; Woodruff PG; Paine R; Barr RG; Hoidal J; Doerschuk CM; Charbonnier JP; Sung R; Locantore N; Yonchuk JG; Jacobson S; Tal-Singer R; Merrill D; Bowler RP
Respir Res; 2021 Apr; 22(1):127. PubMed ID: 33906653
[TBL] [Abstract][Full Text] [Related]
4. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
[TBL] [Abstract][Full Text] [Related]
5. The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients.
Kinjo T; Kitaguchi Y; Droma Y; Yasuo M; Wada Y; Ueno F; Ota M; Hanaoka M
Sci Rep; 2020 Jul; 10(1):12811. PubMed ID: 32732977
[TBL] [Abstract][Full Text] [Related]
6. Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis.
Manichaikul A; Sun L; Borczuk AC; Onengut-Gumuscu S; Farber EA; Mathai SK; Zhang W; Raghu G; Kaufman JD; Hinckley-Stukovsky KD; Kawut SM; Jelic S; Liu W; Fingerlin TE; Schwartz DA; Sell JL; Rich SS; Barr RG; Lederer DJ
Ann Am Thorac Soc; 2017 May; 14(5):628-635. PubMed ID: 28248552
[TBL] [Abstract][Full Text] [Related]
7. AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis.
Yamaguchi K; Iwamoto H; Horimasu Y; Ohshimo S; Fujitaka K; Hamada H; Mazur W; Kohno N; Hattori N
Respirology; 2017 Jul; 22(5):965-971. PubMed ID: 28198072
[TBL] [Abstract][Full Text] [Related]
8. The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.
Miller S; Henry AP; Hodge E; Kheirallah AK; Billington CK; Rimington TL; Bhaker SK; Obeidat M; Melén E; Merid SK; Swan C; Gowland C; Nelson CP; Stewart CE; Bolton CE; Kilty I; Malarstig A; Parker SG; Moffatt MF; Wardlaw AJ; Hall IP; Sayers I
PLoS One; 2016; 11(10):e0164041. PubMed ID: 27755550
[TBL] [Abstract][Full Text] [Related]
9. Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.
Yonchuk JG; Silverman EK; Bowler RP; Agustí A; Lomas DA; Miller BE; Tal-Singer R; Mayer RJ
Am J Respir Crit Care Med; 2015 Oct; 192(7):785-92. PubMed ID: 26132989
[TBL] [Abstract][Full Text] [Related]
10. Receptor for advanced glycation end products polymorphisms in coronary artery ectasia.
Aslan EI; Ozkara G; Kilicarslan O; Ser OS; Bostan C; Yildiz A; Diren Borekcioglu A; Ozturk O; Kucukhuseyin O; Yilmaz Aydogan H
Gene; 2024 Jul; 916():148450. PubMed ID: 38588932
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in the receptor for advanced glycation end products (RAGE) gene were associated with circulating soluble RAGE level but not with renal function among Asians with type 2 diabetes: a genome-wide association study.
Lim SC; Dorajoo R; Zhang X; Wang L; Ang SF; Tan CSH; Yeoh LY; Ng XW; Li N; Su C; Liu S; Wong MDS; Low KMS; Yao AO; Babitha J; Fun S; Zhou S; Lee SBM; Tang WE; Tavintharan S; Sum CF; Liu JJ
Nephrol Dial Transplant; 2017 Oct; 32(10):1697-1704. PubMed ID: 27448675
[TBL] [Abstract][Full Text] [Related]
12. Circulating concentrations of soluble receptor for AGE are associated with age and AGER gene polymorphisms in children with newly diagnosed type 1 diabetes.
Salonen KM; Ryhänen SJ; Forbes JM; Härkönen T; Ilonen J; Laine AP; Groop PH; Knip M;
Diabetes Care; 2014 Jul; 37(7):1975-81. PubMed ID: 24742661
[TBL] [Abstract][Full Text] [Related]
13. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
[TBL] [Abstract][Full Text] [Related]
14. Soluble receptor for advanced glycation end-products and progression of airway disease.
Iwamoto H; Gao J; Pulkkinen V; Toljamo T; Nieminen P; Mazur W
BMC Pulm Med; 2014 Apr; 14():68. PubMed ID: 24758342
[TBL] [Abstract][Full Text] [Related]
15. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
[TBL] [Abstract][Full Text] [Related]
16. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.
Gaens KH; Ferreira I; van der Kallen CJ; van Greevenbroek MM; Blaak EE; Feskens EJ; Dekker JM; Nijpels G; Heine RJ; 't Hart LM; de Groot PG; Stehouwer CD; Schalkwijk CG
J Clin Endocrinol Metab; 2009 Dec; 94(12):5174-80. PubMed ID: 19890027
[TBL] [Abstract][Full Text] [Related]
17. An Integrative Genomic Strategy Identifies sRAGE as a Causal and Protective Biomarker of Lung Function.
Keefe J; Yao C; Hwang SJ; Courchesne P; Lee GY; Dupuis J; Mizgerd JP; O'Connor G; Washko GR; Cho MH; Silverman EK; Levy D
Chest; 2022 Jan; 161(1):76-84. PubMed ID: 34237330
[TBL] [Abstract][Full Text] [Related]
18. Genetics of Plasma Soluble Receptor for Advanced Glycation End-Products and Cardiovascular Outcomes in a Community-based Population: Results from the Atherosclerosis Risk in Communities Study.
Maruthur NM; Li M; Halushka MK; Astor BC; Pankow JS; Boerwinkle E; Coresh J; Selvin E; Kao WH
PLoS One; 2015; 10(6):e0128452. PubMed ID: 26083729
[TBL] [Abstract][Full Text] [Related]
19. Implication of RAGE Polymorphic Variants in COPD Complication and Anti-COPD Therapeutic Potential of sRAGE.
Malik P; Hoidal JR; Mukherjee TK
COPD; 2021 Dec; 18(6):737-748. PubMed ID: 34615424
[TBL] [Abstract][Full Text] [Related]
20. sRAGE levels are decreased in plasma and sputum of COPD secondary to biomass-burning smoke and tobacco smoking: Differences according to the rs3134940 AGER variant.
Fricke-Galindo I; García-Carmona S; Alanis-Ponce J; Pérez-Rubio G; Ramírez-Venegas A; Montiel-Lopez F; Robles-Hernández R; Hernández-Zenteno RJ; Valencia-Pérez Rea D; Bautista-Becerril B; Ramírez-Díaz ME; Cruz-Vicente F; Martínez-Gómez ML; Sansores R; Falfán-Valencia R
Heliyon; 2024 Apr; 10(7):e28675. PubMed ID: 38571598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]